Abstract:Though long recognized, the fundamental basis of the familial nature of asthma and atopy remains elusive. Much effort is currently being focused on identifying genetic markers associated with them, with several different loci being suggested as candidates [1-4]. Segregation analysis suggests that it is unlikely that the genetic factors associated with these disorders are limited to a single or even a few loci, and that other, non-genetic factors influence the overall phenotypic expression of these loci [5]. Thus it would appear that there is an interplay between a number of factors, genetic and environmental, which interact to determine the propensity for an individual to develop atopic disease. When might environment come into play? The role of postnatal exposures in the expression of atopy and asthma have been the subject of much scrutiny. Might not there be influences which exert their effect(s) prenatally, perhaps even affecting the very development of immune function before the foetus has been exposed (in the classical sense) to direct immune challenges from the extra-uterine environment? There is an increasing body of literature suggesting that in newborns the development of specific T-cell response to environmental antigens may occur prior to any first-hand exposure to those antigens, that is, before birth. Szepfalusi and colleagues, in this issue of Clinical and Experimental Allergy [6] , provide further evidence of prenatal priming of T-cells. They document proliferative responses of cord blood mononuclear cells to the cow milk proteins alphalactalbumin, beta-lactoglobulin and alpha-casein which were specific and required the presence of antigen presenting cells to occur. These responses were seen in nearly all of the 39 infants tested. The relevance of these responses to the later development of asthma and/or atopy is unclear, as this and other reports of such responses do not consistently show a relationship to either parental history of atopic disease or subsequent development of such disorders in the infant, though the work reported herein lacks adequate numbers of subjects to conclusively demonstrate the absence of such an association. It would be of interest to know if similar proliferative responses could be elicited by the same antigens in T cells from the mothers, since an association between maternal history of allergy and detectable cord blood IgE and the subsequent development of eczema and wheezing during infancy, an association not found with paternal history of allergy, has been shown [7]. How might antenatal exposure to antigen (and subsequent priming) occur? It is unlikely that intact, whole protein of the sizes used in this study could traverse the placenta. Even so, it is not clear that the foetal immune system is capable of providing the accessory cell function needed to generate a T cell response to them, at least early in gestation [8]. Alternatively, peptides, already 'processed' by the mother, might gain access to the foetal circulation, either independently or in the form of antigen:IgG complexes. The larger question still remains, however. If the majority of infants undergo antigen/allergen priming in utero what other factors might influence the character of their response to antigen exposure and bring about allergic disease later in childhood? A crucial factor in the priming of T cells may be antigen dose. Piccinni and coworkers [9] demonstrated cord blood T cell proliferation in response to Dermatophagoides group I (Der p I) and Lolium group I (Lol p I) allergen, both inhalant allergens, in an unseleeted group of infants. While response to Der p I was found in virtually all of the infants, response to Lol p I was found only in those infants studied around the time of highest environmental levels of that allergen, leading the investigators to suggest that it was the near continuous exposure to Der p I which accounted for the difference. The mother's atopic status may also affect foetal allergen exposure, in that mothers with a predominately IgG response to a given antigen might clear circulating antigen more effectively than mothers with a predominately IgE response. In addition, high dose antigen exposure may shift the nature of the response in a Th2 direction [10]. Along with the dose of antigen presented, the nature of antigen presentation may influence subsequent response. The antigen presenting cell (APC), particularly the dendritic cell (referred to by some as the 'professional APC), may play a crucial role in directing response to antigen. It has been proposed by Matzinger that if naive lymphocytes encounter antigen in the absence of a second signal from a professional APC they will die [11]. A second signal from an appropriate APC, on the other hand, allows the T cell to be become a resting effector cell, ready to respond upon secondary stimulation by antigen. Exactly how the work of Szepfalusi et al. fits into this schema is not clear as the source of (irradiated) APCs used is not specified. However, presumably the effector cells involved were monocytes and/ or macrophages, and not dendritic cells, providing further support that the reactive T cells were 'experienced'. As mentioned previously, there is some suggestion that maternal history of atopy and/or asthma is more strongly

Improving Lithium-Sulfur Battery Performance under Lean Electrolyte Through Nanoscale Confinement in Soft Swellable Gels.

Manipulating Electrolyte and Solid Electrolyte Interphase to Enable Safe and Efficient Li-S Batteries

Quasi-solid-state Sulfur Cathode with Ultralean Electrolyte via In Situ Polymerization

Cutting the cord: is birth already too late for primary prevention of allergy?

Ionic Liquid-Reinforced Carbon Nanofiber Matrix Enabled Lean-Electrolyte Li-S Batteries Via Electrostatic Attraction

A Micelle Electrolyte Enabled by Fluorinated Ether Additives for Polysulfide Suppression and Li Metal Stabilization in Li-S Battery

Fluorinated Co-Solvent Promises Li-S Batteries under Lean-Electrolyte Conditions

Electrolytes with Controlled Polysulfide Insolvability for Lithium-Sulfur Batteries

Boosting High-Performance in Lithium-Sulfur Batteries Via Dilute Electrolyte.

A Lithium/Polysulfide Battery with Dual-Working Mode Enabled by Liquid Fuel and Acrylate-Based Gel Polymer Electrolyte.

Cathode Kinetics Evaluation in Lean-Electrolyte Lithium-Sulfur Batteries

Porous Fe2O3 Doped Cathodes for Lithium-Sulfur Batteries

Concerted Formation of Reversibly Precipitated Sulfur Species and Its Importance for Lean Electrolyte Lithium-Sulfur Batteries

Effective accommodation and conversion of polysulfides using organic-inorganic hybrid frameworks for long-life lithium-sulfur batteries

Moderately Solvating Electrolyte with Fluorinated Cosolvents for Lean‐Electrolyte Li–S Batteries

Cathode–Electrolyte Interfacial Processes in Lithium∥Sulfur Batteries under Lean Electrolyte Conditions

Enhanced Polysulfide Regulation <i>via</i> Porous Catalytic V<sub>2</sub>O<sub>3</sub>/V<sub>8</sub>C<sub>7</sub> Heterostructures Derived from Metal-Organic Frameworks toward High-Performance Li-S Batteries

Development of Electrolytes under Lean Condition in Lithium‐Sulfur Batteries

Rationally Designed in-Situ Gelled Polymer-Ceramic Hybrid Electrolyte Enables Superior Performance and Stability in Quasi-Solid-State Lithium-Sulfur Batteries

Cathode Nanostructuring and Separator Modification for High-Performance Lithium-Sulfur Batteries

An Entangled Cobalt–Nitrogen–Carbon Nanotube Array Electrode with Synergetic Confinement and Electrocatalysis of Polysulfides for Stable Li–S Batteries